🇺🇸 Prednisone+vincristine in United States

689 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Disease Progression — 172 reports (24.96%)
  2. Off Label Use — 134 reports (19.45%)
  3. Lymphoma — 126 reports (18.29%)
  4. Neutropenia — 43 reports (6.24%)
  5. Pyrexia — 42 reports (6.1%)
  6. Diffuse Large B-Cell Lymphoma Recurrent — 39 reports (5.66%)
  7. Death — 37 reports (5.37%)
  8. Drug Ineffective — 37 reports (5.37%)
  9. Product Use In Unapproved Indication — 30 reports (4.35%)
  10. Malignant Neoplasm Progression — 29 reports (4.21%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Prednisone+vincristine approved in United States?

Prednisone+vincristine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Prednisone+vincristine in United States?

Shanghai Children's Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.